through TLR2 Activation T Cells + Infection of Primary Resting CD4 Enhances HIV-1 Neisseria gonorrhoeae

Sexually transmitted infections increase the likelihood of HIV-1 transmission. We investigated the effect of Neisseria gonorrheae (gonococcus [GC]) exposure on HIV replication in primary resting CD4 + T cells, a major HIV target cell during the early stage of sexual transmission of HIV. GC and TLR2 agonists, such as peptidylglycan (PGN), Pam 3 CSK 4 , and Pam 3 C-Lip, a GC-derived synthetic lipopeptide, but not TLR4 agonists including LPS or GC lipooligosaccharide enhanced HIV-1 infection of primary resting CD4 + T cells after viral entry. Pretreatment of CD4 + cells with PGN also promoted HIV infection. Anti-TLR2 Abs abolished the HIV enhancing effect of GC and Pam 3 C-Lip, indicating that GC-mediated enhancement of HIV infection of resting CD4 + T cells was through TLR2. IL-2 was required for TLR2–mediated HIV enhancement. PGN and GC induced cell surface expression of T cell activation markers and HIV coreceptors, CCR5 and CXCR4. The maximal postentry HIV enhancing effect was achieved when PGN was added immediately after viral exposure. Kinetic studies and analysis of HIV DNA products indicated that GC exposure and TLR2 activation enhanced HIV infection at the step of nuclear import. We conclude that GC enhanced HIV infection of primary resting CD4 + T cells through TLR2 activation, which both increased the susceptibility of primary CD4 + T cells to HIV infection as well as enhanced HIV-infected CD4 + T cells at the early stage of HIV life cycle after entry. This study provides a molecular mechanism by which nonulcerative sexually transmitted infections mediate enhancement of HIV infection and has implication for HIV prevention and therapeutics. The Journal of Immunology , 2010, 184: 2814–2824.

[1]  P. A. van der Ley,et al.  Opa+ and Opa− Isolates of Neisseria meningitidis and Neisseria gonorrhoeae Induce Sustained Proliferative Responses in Human CD4+ T Cells , 2009, Infection and Immunity.

[2]  Bizhan Romani,et al.  Human immunodeficiency virus type 1 Vpr: functions and molecular interactions. , 2009, The Journal of general virology.

[3]  A. Blauvelt,et al.  Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. , 2009, Blood.

[4]  G. Doncel,et al.  Biomarkers of Cervicovaginal Inflammation for the Assessment of Microbicide Safety , 2009, Sexually transmitted diseases.

[5]  Y. Aida,et al.  Role of Vpr in HIV-1 nuclear import: therapeutic implications. , 2009, Current HIV research.

[6]  Ruslan Medzhitov,et al.  Pattern recognition receptors and control of adaptive immunity , 2009, Immunological reviews.

[7]  Osamu Takeuchi,et al.  Innate immunity to virus infection , 2009, Immunological reviews.

[8]  M. Tremblay,et al.  TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells , 2009, Retrovirology.

[9]  Lisa M. Lee,et al.  Estimation of HIV incidence in the United States. , 2008, JAMA.

[10]  A. Adimora,et al.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies , 2008, AIDS.

[11]  G. Spear,et al.  TLR2-mediated cell stimulation in bacterial vaginosis. , 2008, Journal of reproductive immunology.

[12]  Wuyuan Lu,et al.  Neisseria gonorrhoeae-Induced Human Defensins 5 and 6 Increase HIV Infectivity: Role in Enhanced Transmission1 , 2008, The Journal of Immunology.

[13]  M. Tremblay,et al.  LPS reduces HIV-1 replication in primary human macrophages partly through an endogenous production of type I interferons. , 2008, Clinical immunology.

[14]  Holger Heine,et al.  Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling , 2008, Journal of leukocyte biology.

[15]  C. Gabay,et al.  The Proinflammatory Cytokine Response to Chlamydia trachomatis Elementary Bodies in Human Macrophages Is Partly Mediated by a Lipoprotein, the Macrophage Infectivity Potentiator, through TLR2/TLR1/TLR6 and CD141 , 2008, The Journal of Immunology.

[16]  C. June,et al.  Addition of Deoxynucleosides Enhances Human Immunodeficiency Virus Type 1 Integration and 2LTR Formation in Resting CD4+ T Cells , 2007, Journal of Virology.

[17]  M. Tremblay,et al.  TLR2 Signaling Renders Quiescent Naive and Memory CD4+ T Cells More Susceptible to Productive Infection with X4 and R5 HIV-Type 11 , 2007, The Journal of Immunology.

[18]  Jialing Huang,et al.  Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes , 2007, Nature Medicine.

[19]  M. Pevsner-Fischer,et al.  Cutting Edge: T Cells Respond to Lipopolysaccharide Innately via TLR4 Signaling1 , 2007, The Journal of Immunology.

[20]  W. Greene,et al.  Regulation of HIV-1 latency by T-cell activation. , 2007, Cytokine.

[21]  K. Forest,et al.  Conserved Regions from Neisseria gonorrhoeae Pilin Are Immunosilent and Not Immunosuppressive , 2007, Infection and Immunity.

[22]  S. Akira,et al.  Cutting Edge: TLR2 Directly Triggers Th1 Effector Functions1 , 2007, The Journal of Immunology.

[23]  X. Liu,et al.  Gonococcal lipooligosaccharide suppresses HIV infection in human primary macrophages through induction of innate immunity. , 2006, The Journal of infectious diseases.

[24]  G. Baldwin,et al.  Repeated lipopolysaccharide (LPS) exposure inhibits HIV replication in primary human macrophages. , 2006, Microbes and infection.

[25]  R. Siliciano,et al.  Nuclear Retention of Multiply Spliced HIV-1 RNA in Resting CD4+ T Cells , 2006, PLoS pathogens.

[26]  A. Jonsson,et al.  Type IV Pili of Neisseria gonorrhoeae Influence the Activation of Human CD4+ T Cells , 2006, Infection and Immunity.

[27]  Arthur M. Krieg,et al.  The Toll-Like Receptor 7 (TLR7) Agonist, Imiquimod, and the TLR9 Agonist, CpG ODN, Induce Antiviral Cytokines and Chemokines but Do Not Prevent Vaginal Transmission of Simian Immunodeficiency Virus When Applied Intravaginally to Rhesus Macaques , 2005, Journal of Virology.

[28]  Johnny J. He,et al.  Neisseria gonorrhoeae Enhances Infection of Dendritic Cells by HIV Type 11 , 2005, The Journal of Immunology.

[29]  E. Gupta,et al.  Enhanced immunocompetent cells in chlamydial cervicitis. , 2004, The Journal of reproductive medicine.

[30]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[31]  D. Chaussabel,et al.  Influence of Coinfecting Pathogens on HIV Expression: Evidence for a Role of Toll-Like Receptors1 , 2004, The Journal of Immunology.

[32]  R. Kaul,et al.  Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. , 2004, JAMA.

[33]  A. Rethwilm,et al.  CpG Oligodeoxynucleotides Activate HIV Replication in Latently Infected Human T Cells* , 2004, Journal of Biological Chemistry.

[34]  R. Stevens Faculty Opinions recommendation of Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. , 2004 .

[35]  C. M. Owens,et al.  The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys , 2004, Nature.

[36]  C. Wijmenga,et al.  The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes , 2003, Nature.

[37]  S. Ram,et al.  The Lip Lipoprotein from Neisseria gonorrhoeae Stimulates Cytokine Release and NF-κB Activation in Epithelial Cells in a Toll-like Receptor 2-dependent Manner* , 2003, Journal of Biological Chemistry.

[38]  A. Sher,et al.  Cutting Edge: In Vivo Induction of Integrated HIV-1 Expression by Mycobacteria Is Critically Dependent on Toll-Like Receptor 2 1 , 2003, The Journal of Immunology.

[39]  S. Dower,et al.  Activation of Toll-Like Receptor 2 (TLR2) and TLR4/MD2 by Neisseria Is Independent of Capsule and Lipooligosaccharide (LOS) Sialylation but Varies Widely among LOS from Different Strains , 2003, Infection and Immunity.

[40]  D. Jans,et al.  Nuclear import of the pre-integration complex (PIC): the Achilles heel of HIV? , 2003, Current drug targets.

[41]  S. Foster,et al.  Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.

[42]  H. Heine,et al.  Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC. , 2003, European journal of biochemistry.

[43]  S. Gray-Owen,et al.  Induction of HIV-1 long terminal repeat-mediated transcription by Neisseria gonorrhoeae. , 2003, AIDS.

[44]  Yasunori Ogura,et al.  Induction of Nod2 in Myelomonocytic and Intestinal Epithelial Cells via Nuclear Factor-κB Activation* , 2002, The Journal of Biological Chemistry.

[45]  Yan Zhou,et al.  Molecular Characterization of Preintegration Latency in Human Immunodeficiency Virus Type 1 Infection , 2002, Journal of Virology.

[46]  R. Hayes,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Hiv-1/aids and the Control of Other Infectious Diseases in Africa , 2022 .

[47]  T. Giese,et al.  Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.

[48]  S. Gray-Owen,et al.  Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes , 2002, Nature Immunology.

[49]  D. Golenbock,et al.  Cutting Edge: Immune Stimulation by Neisserial Porins Is Toll-Like Receptor 2 and MyD88 Dependent1 , 2002, The Journal of Immunology.

[50]  S. Akira,et al.  Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1 , 2001, The Journal of Immunology.

[51]  D. Weissman,et al.  Nonproliferating Bystander CD4+ T Cells Lacking Activation Markers Support HIV Replication During Immune Activation1 , 2001, The Journal of Immunology.

[52]  A. Aderem,et al.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. Akira,et al.  Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection1 , 2000, The Journal of Immunology.

[54]  T. van der Poll,et al.  Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines. , 2000, Blood.

[55]  H. Schuitemaker,et al.  In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[56]  R. Siliciano,et al.  Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. , 2000, Annual review of immunology.

[57]  D. Richman,et al.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. , 1999, Science.

[58]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[59]  Anthony S. Fauci,et al.  Both Memory and CD45RA+/CD62L+ Naive CD4+ T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals , 1999, Journal of Virology.

[60]  J. Griffiss,et al.  Neisseria gonorrhoeae Coordinately Uses Pili and Opa To Activate HEC-1-B Cell Microvilli, Which Causes Engulfment of the Gonococci , 1999, Infection and Immunity.

[61]  J. Andersson,et al.  Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes. , 1999, Clinical immunology.

[62]  W Turner,et al.  Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. , 1998, The Journal of clinical investigation.

[63]  W. Miller,et al.  Sexually transmitted diseases and human immunodeficiency virus infection: cause, effect, or both? , 1998, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[64]  W. Levine,et al.  Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. , 1998, The Journal of infectious diseases.

[65]  P. Ghys,et al.  The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire , 1997, AIDS.

[66]  P. Vernazza,et al.  Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1 , 1997, The Lancet.

[67]  M. Zazzi,et al.  Evaluation of the presence of 2‐LTR HIV‐1 unintegrated DNA as a simple molecular predictor of disease progression , 1997, Journal of medical virology.

[68]  C. Mackay,et al.  The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[69]  O. Ramilo,et al.  Highly purified CD25- resting T cells cannot be infected de novo with HIV-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[70]  R. Connor,et al.  Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals , 1997, The Journal of experimental medicine.

[71]  E. Clark,et al.  Nuclear import of HIV-1 DNA in resting CD4+ T cells requires a cyclosporin A-sensitive pathway. , 1997, Journal of immunology.

[72]  S. P. Sidorenko,et al.  Immunodeficiency virus cDNA synthesis in resting T lymphocytes is regulated by T cell activation signals and dendritic cells , 1996, Journal of medical primatology.

[73]  F. Lori,et al.  HIV-1 Protein Expression from Synthetic Circles of DNA Mimicking the Extrachromosomal Forms of Viral DNA (*) , 1996, The Journal of Biological Chemistry.

[74]  R. Perlmutter,et al.  Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation , 1995, Cell.

[75]  M. Emerman,et al.  Molecular basis of cell cycle dependent HIV-1 replication. Implications for control of virus burden. , 1995, Advances in experimental medicine and biology.

[76]  R. Andino,et al.  Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses , 1994, Journal of virology.

[77]  E. Clark,et al.  T-cell activation influences initial DNA synthesis of simian immunodeficiency virus in resting T lymphocytes from macaques , 1993, Journal of virology.

[78]  M. Bukrinsky,et al.  Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[79]  J. Zack,et al.  Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle , 1992, Journal of virology.

[80]  M P Dempsey,et al.  Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.

[81]  P. Piot,et al.  Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. , 1991, The Journal of infectious diseases.

[82]  Jerome A. Zack,et al.  HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.

[83]  R. Brunham,et al.  FEMALE TO MALE TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1: RISK FACTORS FOR SEROCONVERSION IN MEN , 1989, The Lancet.

[84]  Kendall A. Smith,et al.  Interleukin-2: inception, impact, and implications. , 1988, Science.